权变视角下知识重组对技术创新质量的影响基于中国医药制造业企业的实证研究

Effects of Knowledge Recombination on Technological Innovation Quality from the Perspective of Contingency——Evidence from Chinese Pharmaceutical Industry

基于知识基础理论,以中国医药制造业1999—2014年982家企业为研究对象,运用固定效应的负二项回归模型,从权变视角探讨企业年龄如何影响探索式知识重组和利用式知识重组与企业技术创新质量的关系,实证结果表明:探索式知识重组和利用式知识重组均与企业技术创新质量正相关,但探索式知识重组的正向作用强于利用式知识重组,且二者的组合效应与技术创新质量负相关;企业年龄有利于增强探索式知识重组对企业技术创新质量的正向作用,但在利用式知识重组与企业技术创新质量的关系中发挥负向调节作用。企业在进行技术创新活动时,不应只局限于考虑知识重组行为本身的优劣性,而应综合考虑知识重组行为与企业自身条件的匹配度。

Drawing upon the patent data of 982 Chinese pharmaceutical firms between 1999 and 2014,this paper uses the knowledge-based theory to investigate,from the perspective of contingency,how firm age impacts the relationship between different knowledge recombination,i.e.,recombinant exploration and recombinant exploitation,and firms’technological innovation quality.A negative binomial regression of the fixed effects model is incorporated to test the theoretical hypotheses,and the empirical analysis shows that both recombinant exploration and recombinant exploitation positively and significantly affect technological innovation quality,and the positive effect of recombinant exploration is stronger than that of recombinant exploitation.However,recombinant exploration and exploitation jointly and negatively influence firms’technological innovation quality.Further,firm age strengthens the positive impact of recombinant exploration on technological innovation quality while it weakens the positive impact of recombinant exploitation on technological innovation quality.In the process of technological innovation,firms should not only consider the merits and disadvantages of knowledge recombination but also consider the matching degree of knowledge recombination and their own conditions.